Essex Investment Management CO LLC Incyte Corp Transaction History

Essex Investment Management CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$70.23 - $86.01 $228,949 - $280,392	3,260 Added 21.42%	18,481 $1.34 Million
Q4 2022 Feb 02, 2023	BUY	$67.18 - $84.11 $1.02 Million - $1.28 Million	15,221 New	15,221 $1.22 Million
Q2 2019 Aug 15, 2019	SELL	$73.52 - $88.7 $1.18 Million - $1.42 Million	-16,018 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1.02 Million - $1.41 Million	16,018 New	16,018 $1.38 Million
Q2 2018 Jul 17, 2018	SELL	$60.85 - $83.98 $2.13 Million - $2.94 Million	-34,985 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$83.06 - $100.98 $246,023 - $299,102	-2,962 Reduced 7.81%	34,985 $2.92 Million
Q4 2017 Feb 05, 2018	SELL	$93.56 - $116.6 $99,734 - $124,295	-1,066 Reduced 2.73%	37,947 $3.59 Million
Q3 2017 Oct 30, 2017	BUY	$109.15 - $138.27 $4.26 Million - $5.39 Million	39,013	39,013 $4.55 Million

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.